Templates for CMC strategy playbooks by modality and product type Templates for CMC Strategy Playbooks by Modality and Product Type Context In the realm of pharmaceutical and biotechnology development, the Chemistry, Manufacturing, and Controls (CMC) strategy lifecycle is a fundamental aspect that dictates the course of product development from preclinical phases through to commercial marketing. Establishing a coherent CMC strategy is essential not just for regulatory compliance but also for the holistic integration of development efforts across various disciplines, including Clinical, Quality Assurance (QA), Pharmacovigilance (PV), and Commercialization. This article aims to provide a detailed regulatory explainer manual for crafting…

Global CMC Strategy Alignment Across FDA, EMA and Other Agencies Global CMC Strategy Alignment Across FDA, EMA and Other Agencies In the complex landscape of pharmaceutical and biotech product development, maintaining a robust Chemistry, Manufacturing, and Controls (CMC) strategy throughout the entire product lifecycle is critical. This article serves as a comprehensive regulatory explainer manual, outlining key considerations for aligning CMC strategies across global regulatory agencies, including the FDA, EMA, and MHRA. Context of Regulatory Affairs in CMC Strategy Lifecycle The CMC strategy lifecycle involves several stages—from early development through to commercialization—and necessitates a proactive approach to meet regulatory expectations….

Scenario planning in CMC strategy for capacity, sites and risk events Scenario Planning in CMC Strategy for Capacity, Sites and Risk Events Effective management of Chemistry, Manufacturing, and Controls (CMC) is critical throughout the product lifecycle, from early development to commercialization. This document provides a regulatory explainer manual on scenario planning in CMC strategy, focusing on capacity, sites, and risk events. This guide aims to align with FDA, EMA, MHRA expectations and provide actionable insights for Kharma and regulatory professionals. Context As pharmaceuticals and biotechnology companies navigate the complexities of CMC strategy, scenario planning is essential for anticipating capacity needs,…

Metrics and KPIs to Track Execution of Your CMC Lifecycle Strategy Metrics and KPIs to Track Execution of Your CMC Lifecycle Strategy In the global pharmaceutical and biotechnology landscape, an effective Chemistry, Manufacturing, and Controls (CMC) strategy lifecycle is critical for regulatory success and product commercialization. Regulatory Affairs (RA) professionals must understand the various metrics and key performance indicators (KPIs) that track CMC strategy execution from early development through to commercialization. This article serves as an exhaustive guide to the regulatory expectations and documentation practices, providing insights into the integration of CMC with Clinical, Pharmacovigilance (PV), Quality Assurance (QA), and…

Incorporating Device and Packaging Considerations into CMC Planning Incorporating Device and Packaging Considerations into CMC Planning The complexity of the pharmaceutical and biotechnology industries necessitates a comprehensive understanding of Chemistry, Manufacturing, and Controls (CMC) lifecycle management. This article aims to elucidate the critical intersection of device and packaging considerations within CMC strategy from early development to commercialization. Professionals in Regulatory Affairs (RA), Quality Assurance (QA), and related fields will benefit from a structured overview of relevant regulations, guidelines, and agency expectations across major jurisdictions, including the US, UK, and EU. Context Incorporating device and packaging considerations is imperative for a…